Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5780)
  3. Review (420)
  4. Editorial (194)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13274)
  2. Center for Hematologic Malignancies (10609)
  3. GSK Faculty (4481)
  4. Adult Leukemia (3672)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2704)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (336)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (329)
  5. Haematologica (291)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1529)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13375)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): Focus on the use of tagraxofusp and clinical considerations
    Review

    Pemmaraju, N.; Madanat, Y. F.; Rizzieri, D.; Fazal, S.; Rampal, R.; Mannis, G.; Wang, E. S.; Foran, J.; Lane, A. A.
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Advances in human epidermal growth factor receptor 2-targeted therapy in upper gastrointestinal cancers
    Review

    Lee, J.; Ku, G.
    Hematology/Oncology Clinics of North America (2024)

    Fulltext@MSK | Save
  • Moving towards establishing centres of excellence in cardiac amyloidosis: An International Cardio-Oncology Society statement
    Review

    Cheng, R.; Kittleson, M. M.; Wechalekar, A. D.; Alvarez-Cardona, J.; Mitchell, J. D.; Scarlatelli Macedo, A. V.; Dutra, J. P. P.; Campbell, C. M.; Liu, J. E.; Landau, H. J.; more...
    Heart (2024)

    Fulltext@MSK | Save
  • Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas
    Journal Article

    Soumerai, J. D.; Diefenbach, C. S.; Jagadeesh, D.; Asch, A.; Kumar, A.; Tsai, M. L.; Jandl, T. A.; Lossos, I. S.; Kenkre, V. P.; Awan, F.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Second primary malignancies after commercial CAR T-cell therapy: Analysis of the FDA Adverse Events Reporting System
    Research Letter

    Elsallab, M.; Ellithi, M.; Lunning, M. A.; D'Angelo, C.; Ma, J.; Perales, M. A.; Frigault, M.; Maus, M. V.
    Blood (2024)

    Fulltext@MSK | Save
  • Palliative medicine in myelodysplastic syndromes: Patients and caregivers - A qualitative study
    Journal Article

    Desai, A. V.; Klimek, V. M.; Wan, P. J.; Heinberg, A.; Anderson, K. L.; Bernal, C.; Nelson, J. E.
    BMJ Supportive & Palliative Care (2024)

    Fulltext@MSK | Save
  • Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation
    Journal Article

    Melica, G.; Preston, E.; Palazzo, M.; Seier, K.; Malard, F.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Maslak, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis
    Journal Article

    Costa, B. A.; Costa, T. A.; Saravia, S. D.; Felix, N.; Tan, C. R.; Korde, N.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison of brexucabtagene autoleucel (ZUMA-2) and pirtobrutinib (BRUIN) in patients with relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor
    Journal Article

    Salles, G.; Chen, J. M. H.; Zhang, I.; Kerbauy, F.; Wu, J. J.; Wade, S. W.; Nunes, A.; Feng, C.; Kloos, I.; Peng, W.; more...
    Advances in Therapy (2024)

    Fulltext@MSK | Save